RNA-Targeted Small Molecule Drugs Market, Global Outlook and Forecast 2023-2029

Report ID: MMG9170 | Category: Service & Software | Pages: 105 | Format: PDF | Published Date: February 14,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for RNA-Targeted Small Molecule Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA-Targeted Small Molecule Drugs. This report contains market size and forecasts of RNA-Targeted Small Molecule Drugs in global, including the following market information:
Global RNA-Targeted Small Molecule Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global RNA-Targeted Small Molecule Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
mRNA Translation Regulation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNA-Targeted Small Molecule Drugs include Roche, Novartis, PTC Therapeutics, Biogen, Accent Therapeutics, Anima Biotech, Arrakis Pharmaceuticals, Epics Therapeutics and Expansion Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNA-Targeted Small Molecule Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA-Targeted Small Molecule Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, by Type, 2022 (%)
    mRNA Translation Regulation
    RNA Splicing Modification
    Direct RNA Targeting
    Indirect RNA Targeting - Epitranscriptomics
Global RNA-Targeted Small Molecule Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, by Application, 2022 (%)
    SMA
    Oncology
    Lung Fibrosis
    Huntington's Disease
    Others
Global RNA-Targeted Small Molecule Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global RNA-Targeted Small Molecule Drugs Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA-Targeted Small Molecule Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies RNA-Targeted Small Molecule Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Roche
    Novartis
    PTC Therapeutics
    Biogen
    Accent Therapeutics
    Anima Biotech
    Arrakis Pharmaceuticals
    Epics Therapeutics
    Expansion Therapeutics
    Gotham Therapeutics
    H3 Biomedicine
    Ribometrix
    Skyhawk Therapeutics
    STORM Therapeutics
    Twentyeight-Seven Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA-Targeted Small Molecule Drugs, market overview.
Chapter 2: Global RNA-Targeted Small Molecule Drugs market size in revenue.
Chapter 3: Detailed analysis of RNA-Targeted Small Molecule Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA-Targeted Small Molecule Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 RNA-Targeted Small Molecule Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global RNA-Targeted Small Molecule Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global RNA-Targeted Small Molecule Drugs Overall Market Size
    2.1 Global RNA-Targeted Small Molecule Drugs Market Size: 2022 VS 2029
    2.2 Global RNA-Targeted Small Molecule Drugs Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top RNA-Targeted Small Molecule Drugs Players in Global Market
    3.2 Top Global RNA-Targeted Small Molecule Drugs Companies Ranked by Revenue
    3.3 Global RNA-Targeted Small Molecule Drugs Revenue by Companies
    3.4 Top 3 and Top 5 RNA-Targeted Small Molecule Drugs Companies in Global Market, by Revenue in 2022
    3.5 Global Companies RNA-Targeted Small Molecule Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Players in Global Market
        3.6.1 List of Global Tier 1 RNA-Targeted Small Molecule Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global RNA-Targeted Small Molecule Drugs Market Size Markets, 2022 & 2029
        4.1.2 mRNA Translation Regulation
        4.1.3 RNA Splicing Modification
        4.1.4 Direct RNA Targeting
        4.1.5 Indirect RNA Targeting - Epitranscriptomics
    4.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
        4.2.1 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
        4.2.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
        4.2.3 By Type - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global RNA-Targeted Small Molecule Drugs Market Size, 2022 & 2029
        5.1.2 SMA
        5.1.3 Oncology
        5.1.4 Lung Fibrosis
        5.1.5 Huntington's Disease
        5.1.6 Others
    5.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
        5.2.1 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
        5.2.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
        5.2.3 By Application - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global RNA-Targeted Small Molecule Drugs Market Size, 2022 & 2029
    6.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
        6.2.1 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
        6.2.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
        6.2.3 By Region - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
        6.3.2 US RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.3.3 Canada RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.3.4 Mexico RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
        6.4.2 Germany RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.4.3 France RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.4.4 U.K. RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.4.5 Italy RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.4.6 Russia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.4.7 Nordic Countries RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.4.8 Benelux RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
        6.5.2 China RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.5.3 Japan RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.5.4 South Korea RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.5.5 Southeast Asia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.5.6 India RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
        6.6.2 Brazil RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.6.3 Argentina RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
        6.7.2 Turkey RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.7.3 Israel RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.7.4 Saudi Arabia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
        6.7.5 UAE RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
7 RNA-Targeted Small Molecule Drugs Companies Profiles
    7.1 Roche
        7.1.1 Roche Company Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.1.4 Roche RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.1.5 Roche Key News & Latest Developments
    7.2 Novartis
        7.2.1 Novartis Company Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.2.4 Novartis RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.2.5 Novartis Key News & Latest Developments
    7.3 PTC Therapeutics
        7.3.1 PTC Therapeutics Company Summary
        7.3.2 PTC Therapeutics Business Overview
        7.3.3 PTC Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.3.4 PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.3.5 PTC Therapeutics Key News & Latest Developments
    7.4 Biogen
        7.4.1 Biogen Company Summary
        7.4.2 Biogen Business Overview
        7.4.3 Biogen RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.4.4 Biogen RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.4.5 Biogen Key News & Latest Developments
    7.5 Accent Therapeutics
        7.5.1 Accent Therapeutics Company Summary
        7.5.2 Accent Therapeutics Business Overview
        7.5.3 Accent Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.5.4 Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.5.5 Accent Therapeutics Key News & Latest Developments
    7.6 Anima Biotech
        7.6.1 Anima Biotech Company Summary
        7.6.2 Anima Biotech Business Overview
        7.6.3 Anima Biotech RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.6.4 Anima Biotech RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.6.5 Anima Biotech Key News & Latest Developments
    7.7 Arrakis Pharmaceuticals
        7.7.1 Arrakis Pharmaceuticals Company Summary
        7.7.2 Arrakis Pharmaceuticals Business Overview
        7.7.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.7.4 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.7.5 Arrakis Pharmaceuticals Key News & Latest Developments
    7.8 Epics Therapeutics
        7.8.1 Epics Therapeutics Company Summary
        7.8.2 Epics Therapeutics Business Overview
        7.8.3 Epics Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.8.4 Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.8.5 Epics Therapeutics Key News & Latest Developments
    7.9 Expansion Therapeutics
        7.9.1 Expansion Therapeutics Company Summary
        7.9.2 Expansion Therapeutics Business Overview
        7.9.3 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.9.4 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.9.5 Expansion Therapeutics Key News & Latest Developments
    7.10 Gotham Therapeutics
        7.10.1 Gotham Therapeutics Company Summary
        7.10.2 Gotham Therapeutics Business Overview
        7.10.3 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.10.4 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.10.5 Gotham Therapeutics Key News & Latest Developments
    7.11 H3 Biomedicine
        7.11.1 H3 Biomedicine Company Summary
        7.11.2 H3 Biomedicine Business Overview
        7.11.3 H3 Biomedicine RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.11.4 H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.11.5 H3 Biomedicine Key News & Latest Developments
    7.12 Ribometrix
        7.12.1 Ribometrix Company Summary
        7.12.2 Ribometrix Business Overview
        7.12.3 Ribometrix RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.12.4 Ribometrix RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.12.5 Ribometrix Key News & Latest Developments
    7.13 Skyhawk Therapeutics
        7.13.1 Skyhawk Therapeutics Company Summary
        7.13.2 Skyhawk Therapeutics Business Overview
        7.13.3 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.13.4 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.13.5 Skyhawk Therapeutics Key News & Latest Developments
    7.14 STORM Therapeutics
        7.14.1 STORM Therapeutics Company Summary
        7.14.2 STORM Therapeutics Business Overview
        7.14.3 STORM Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.14.4 STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.14.5 STORM Therapeutics Key News & Latest Developments
    7.15 Twentyeight-Seven Therapeutics
        7.15.1 Twentyeight-Seven Therapeutics Company Summary
        7.15.2 Twentyeight-Seven Therapeutics Business Overview
        7.15.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
        7.15.4 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
        7.15.5 Twentyeight-Seven Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

RNA-Targeted Small Molecule Drugs Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?